The company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.90) by $0.27, FiscalAI reports. ImageneBio Trading Up 0.7%Shares of ImageneBio stock traded up $0.04 during trading on Wednesday, hitting $5.75. Finally, Wall Street Zen cut ImageneBio from a “sell” rating to a “strong sell” rating in a research report on Sunday, May 17th. Vanguard Group Inc. purchased a new position in shares of ImageneBio during the third quarter worth about $1,902,000. Finally, Citadel Advisors LLC bought a new position in shares of ImageneBio in the third quarter worth approximately $996,000.